🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Combination approaches will almost certainly be required to generate durabl...
Status
Completed
Location
Zuckerberg San Francisco General Hospital, University of California San Francisco
Start Date
2020-08-01
Trial ID
NCT04357821
Treatments Being Tested
This randomized study will examine the efficacy, safety and acceptability o...
Status
Completed
Location
Hôpital de District Sanitaire Dandé
Start Date
2004-07
Trial ID
NCT00670761
Treatments Being Tested
The study is aimed at assessing the safety and immunogenicity of HCV prime-...
Status
Completed
Location
Centre for Cinical Vaccinology and Tropical Medicine, Univeristy of Oxford
Start Date
2017-12-04
Trial ID
NCT03688061
Treatments Being Tested
The purpose of this study is to evaluate the role of combination therapy wi...
Status
Terminated
Location
Baylor College of Medicine - Methodist Hospital
Start Date
2007-08
Trial ID
NCT00521274
This study is a multi-center, double-blind, placebo-controlled, Phase I stu...
Status
Completed
Location
University of Iowa - Vaccine Research and Education Unit
Start Date
2016-07-05
Trial ID
NCT02743455
Treatments Being Tested
This randomized clinical trial (RCT) evaluates whether metformin can reduce...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-04-07
Trial ID
NCT06829238
The goal of this clinical trial is to compare success rates of two removal ...
Status
Active Not Recruiting
Location
Comprehensive Women's Health Center
Start Date
2023-01-01
Trial ID
NCT05702242
Treatments Being Tested
This Phase 2 study aims to improve preparedness for future Ebola outbreaks ...
Status
Completed
Location
Hôpital Général de Référence de Boende
Start Date
2019-12-18
Trial ID
NCT04186000
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
This study will be a two-arm prospective 1:1 randomised controlled trial co...
Status
Completed
Location
Brighton and Sussex University Hospitals NHS Trust
Start Date
2015-11-27
Trial ID
NCT02336074